Stay updated on Pediatric CLN2 Disease Clinical Trial
Sign up to get notified when there's something new on the Pediatric CLN2 Disease Clinical Trial page.

Latest updates to the Pediatric CLN2 Disease Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase 2 study evaluating BMN 190 for CLN2 disease, while adding references to Jansky-Bielschowsky Disease and related conditions.SummaryDifference20%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 17, 2025. However, the removal of the date March 25, 2025, indicates a potential change in future content or scheduling.SummaryDifference0.4%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 17, 2025, and version 2.14.2.SummaryDifference0.2%
- Check66 days agoChange DetectedDifference0.1%
- Check73 days agoChange DetectedThe web page has been updated to reflect the completion of enrollment for a study on BMN 190 in pediatric patients with CLN2 disease, along with new results and analysis metrics related to the study's efficacy and safety. Key dates for results submission and posting have also been added.SummaryDifference83%
Stay in the know with updates to Pediatric CLN2 Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric CLN2 Disease Clinical Trial page.